{"disease":{"id":"left-ventricular-septal-hypertrophy","name":"left ventricular septal hypertrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06269640","title":"NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study","phase":"NA","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}